On Thursday shares of China Information Technology, Inc. (NASDAQ:CNIT) closed at $3.99. Company’s sales growth for last 5 years was -2.30% and EPS growth for next 5 years is recorded as 23.00%. On 11 March 2015, China Information Technology, Inc (NASDAQ:CNIT) announced that a leading advertising agency has selected the Company to install 20,000 cloud-based new media elevator terminals in Guangdong province.
XOMA Corporation (NASDAQ:XOMA) in last trading activity increased 4.02% to close at $4.14. Company weekly performance is 9.52% while its quarterly performance stands at -0.24%. XOMA Corporation (NASDAQ:XOMA) is -35.81% away from its 52 week high. XOMA Corporation (NASDAQ:XOMA) on March 11, 2015, declared its operational highlights and financial results for the quarter and year ended December 31, 2014. The financial results for 2014 reflect reduced reimbursements from SERVIER associated with gevokizumab development activities, as SERVIER met the initial $50 million cap of fully reimbursable non-infectious intermediate, posterior, or pan-uveitis (NIU) and Behcet’s diseases uveitis costs during the third quarter of 2013.
On last trading day Simmons First National Corporation (NASDAQ:SFNC) remains unchanged to close at $44.15. Its volatility for the week is 1.27% while volatility for the month is 1.74%. SFNC’s sales growth for past 5 years was 6.30% and its EPS growth for past 5 years was 3.90%. Simmons First National Corporation (NASDAQ:SFNC) monthly performance is 12.54%.
On Thursday shares of International Business Machines Corporation (NYSE:IBM) closed at $159.81. Company’s sales growth for last 5 years was -0.60% and EPS growth for next 5 years is recorded as 4.51%. International Business Machines Corporation (NYSE:IBM)’s CEO says the company’s plan to revamp its business to shift away from hardware and focus on business analytics, cloud computing, mobile services and security is on track.
On last trading day Hemispherx Biopharma, Inc. (NYSEMKT:HEB) remains unchanged to close at $0.23. Its volatility for the week is 7.21% while volatility for the month is 6.74%. HEB’s sales growth for past 5 years was -7.80% and its EPS growth for past 5 years was 9.00%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) monthly performance is -11.54%.Hemispherx Biopharma, Inc. (NYSE MKT:HEB) reported on 9 March 2015, that it has executed an agreement with Emerge Health Pty Ltd. (“Emerge”) to seek approval of Ampligen, an experimental immunotherapeutic, for Chronic Fatigue Syndrome in Australia and New Zealand and to commence distribution of Ampligen in both countries on a named-patient basis, where deemed appropriate.